1) Risk stratification
危险度分层
1.
Relationship between level of matrix metalloproteinase-1 and risk stratification in the patients with unstable angina;
基质金属蛋白酶-1水平与不稳定性心绞痛危险度分层的关系
2.
Using the combination of the myocardial perfusion and poststress ejection fraction(EF) by the gated myocardial SPECT in the risk stratification for the patients who had coronary artery diseases to assess the risk of nonfatal myocardial infarction versus cardiac death can assist in determining the appropri-ate treatment strategy for the individual patient.
应用门控心肌灌注SPECT测得的心肌灌注缺损和负荷后左室射血分数(leftventricu鄄larejectionfraction,LVEF)相结合进行危险度分层,对非致死性心肌梗死和心脏性死亡的风险进行评估以指导临床选择最佳治疗方案。
3.
Many clinical trials have proven nuclear myocardial perfusion imaging may take a key role in diagnoses, risk stratification and management of coronary artery disease.
多项临床试验证明,核素心肌灌注显像在冠心病诊断、危险度分层、预后判断、病人处理方案等方面具有突出的作用和优越的价值。
2) Risk stratification
危险分层
1.
Value of APACHE-Ⅱ score on risk stratification in patients with acute myocardial infarction;
入院时APACHE-Ⅱ评分在急性心肌梗死患者危险分层中的应用价值
2.
The roles of hsCRP on risk stratification and prognosis in patients with heart failure;
超敏C反应蛋白对心力衰竭患者的危险分层及预后判断
3.
Risk stratification and therapeutic strategy for patients with non-ST-elevation acute coronary syndrome;
非ST段抬高急性冠脉综合征的危险分层和治疗策略
3) Dangerous classification
危险分层
1.
Objective: To investigate the changes of the serum levels of interleukin-6(IL-6), C-reactive protein(CRP) and tumor necrosis factor- a (TNF- a ) in the unstable angina pectoris(UAP) and to assess the significance in the dangerous classification and the prognostic value of UAP.
目的：探讨不稳定性心绞痛(UAP)患者血清白细胞介素-6(IL-6)、C-反应蛋白(CRP)和肿瘤坏死因子-α(TNF-α)水平变化及其在危险分层和预后判断中的意义。
6) Fine's risk classification
Fine 危险分层
补充资料：人群特异危险度
人群特异危险度
是测量在人群中因暴露于某因素所致的发病率或死亡率。从公式表示：PAR＝It-Iu式中It——全人群某病发病率或死亡率Iu——非暴露者某病发病率或死亡率人群特异危险度百分比(PAR%)是人群由因暴露于某因素所致病或死亡占人群发病或死亡的百分比。PAR%＝〓〓It-Iu〓〓It〓〓×100%
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条